Allergic-Disease Findings in 169 Elite Pediatric Swimmers

November 12, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional activity, training or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.

Reader question: What did this exact study measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?

Study snapshot

Study element	Reported detail
Population	169 elite pediatric swimmers in Istanbul; 84 underwent additional objective allergy, airway and biomarker assessments.
Design	Cross-sectional ISAAC-questionnaire study with an objectively tested subset.
Comparator	Cumulative pool exposure and swimming duration were compared with allergic-disease reports, atopy and objective airway or epithelial markers.
Timepoint	Single assessment; median swimming duration was 36 months and median cumulative pool attendance 1,430 hours.
Key result	Atopy prevalence was 41.6%; current eczema was 4.8% and physician-diagnosed eczema 7.1%. Cumulative chlorinated-pool exposure was not associated with allergic disease or objective markers, while longer duration findings were exploratory.
Funding/conflict context	Funding and conflict declarations should be reviewed in the full article; PubMed indexing does not imply endorsement.

What was actually measured?

Atopy prevalence was 41.6%; current eczema was 4.8% and physician-diagnosed eczema 7.1%. Cumulative chlorinated-pool exposure was not associated with allergic disease or objective markers, while longer duration findings were exploratory.

The null cumulative-exposure result must remain null; an exploratory duration association does not overturn the primary cross-sectional finding.

The denominator defines the claim. People, visits, infections, episodes, isolates, feet and blisters are different analytic units. A percentage or rate using one unit cannot be silently rewritten as the percentage of people affected.

What the result does not prove

Cross-sectional timing, pediatric elite selection and a tested subset limit causal inference and generalizability; early-life and tobacco exposures may confound subgroup analyses.

Association and timing do not automatically prove individual causation. Footwear, surfaces, climate, ultraviolet exposure, hygiene, protective equipment, training load, prior conditions, referral patterns and access to care may change an estimate.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.

Keep the condition categories separate

Dryness, friction injury, sunburn, dermatitis, sensitization, fungal disease and bacterial infection are not interchangeable. A moisturizer may support hydration and the moisture barrier, but it does not diagnose infection, prevent ultraviolet injury, replace medical evaluation or substitute for activity-specific prevention.

Persistent spreading redness, drainage, fever, severe pain, rapidly worsening symptoms, a suspected contagious outbreak or major loss of function warrants prompt professional assessment. Clinicians may need microscopy, culture, patch testing, skin-prick testing or other targeted evaluation depending on the question.

Activity details worth documenting

What surface, footwear, sock, glove, mat, pool, boat, uniform, animal, climate or training load preceded the change?
Where did the problem begin, and did it change during rest, travel, deployment, competition or a different facility?
Were towels, clothing, footwear, razors, equipment or showers shared, and how were high-touch surfaces cleaned?
How often was skin wet, occluded, rubbed, heated, chilled or exposed to sun?
Did the problem alter sleep, pace, attendance, training, competition, work safety or duty status?

Prevention comes before cosmetic care

Prevention should match the hazard: well-fitted and broken-in equipment, task-appropriate textiles, friction management, clean personal gear, facility hygiene, prompt showering, ultraviolet protection and timely clinical assessment. No single intervention prevents every diagnosis.

Do not share personal skin products during an outbreak and do not test workplace, sport or environmental materials directly on skin. Follow occupational-health, sports-medicine, public-health and facility instructions for contagious or exposure-related conditions.

Primary research and authoritative guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, infection, blisters, sunburn or sensitization; relieves pain or itch; neutralizes environmental exposures; is appropriate for every person; or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace, sports, military, maritime, animal-exposure or infection-control determination.

← Back to Doctor's Notes